Evidence-Based Benefits
- Enhanced MPOD — the CREST study found that a three-carotenoid formula (10 mg meso-zeaxanthin, 10 mg lutein, 2 mg zeaxanthin) increased MPOD significantly more than lutein/zeaxanthin alone over 12 months
- Foveal center protection — meso-zeaxanthin is the dominant pigment at the epicenter of the fovea, providing the last line of antioxidant defense for cone photoreceptors
- Visual performance — supplementation with all three macular carotenoids improved contrast sensitivity and glare disability in the CREST AMD study
- Antioxidant synergy — meso-zeaxanthin is a more potent singlet oxygen quencher than either lutein or zeaxanthin individually